Abstract
This retrospective study in 20 untreated type I Gaucher disease patients shows that in Dutch patients clinical manifestations of Gaucher disease type I are progressive in the majority of patients, children as well as adults. This is in contrast with studies among Jewish patients. Our results emphasize the need for a regular follow-up to enable timely initiation of enzyme therapy.
Similar content being viewed by others
REFERENCES
Barton NW, Furbish FS, Murray GJ, Garfield M, Brady RO (1990) Therapeutic response to intravenous administration of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci USA 87: 1913-1916.
Beutler E, Grabowski GA (1995) Gaucher disease. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2641-2670.
Beutler E, Demina A, Laubscher K, et al (1995) The clinical course of treated and untreated Gaucher disease. A study of 45 patients. Blood Cells, Mol Dis 21: 86-106.
Boot RG, Hollak CE, Verhoek M, et al (1997) Glucocerebrosidase genotype of Gaucher patients in the Netherlands: limitations in prognostic value. Hum Mutat 10: 348-358.
Hollak CEM, Aerts JMFG, Goudsmit R, et al (1995) Individualised low-dose alglucerase therapy for type 1 GaucherÏs disease. Lancet 345: 1474-1478.
Ida H, Rennert OM, Ito T, Maekawa K, Yoshikatsu E (1998) Type 1 Gaucher disease: phenotypic expression and natural history in Japanese patients. Blood cells, Mol Dis 24: 73-81.
Niederau C, Brikhahn A, Ehlen C, Haussinger D (1996) Facts and fiction of modern diagnosis of type 1 Gaucher disease: the German experience. Gaucher Clin Perspect 4: 5-13.
Poll RG, van den Hark ACBM (1991) Orthopedic problems in Dutch Gaucher patients. Acta Orthop Scand 62 (supplement 246): 31.
Zimran A, Kay A, Gelbart T, et al (1992) Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine 71: 337-353.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maaswinkel-Mooij, P., Hollak, C., Van Eysden-Plaisier, M. et al. The natural course of Gaucher disease in The Netherlands: Implications for monitoring of disease manifestations. J Inherit Metab Dis 23, 77–82 (2000). https://doi.org/10.1023/A:1005655031239
Issue Date:
DOI: https://doi.org/10.1023/A:1005655031239